172 related articles for article (PubMed ID: 29743316)
21. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
[TBL] [Abstract][Full Text] [Related]
22. Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.
Bernard NF
AIDS Res Ther; 2017 Sep; 14(1):38. PubMed ID: 28893287
[TBL] [Abstract][Full Text] [Related]
23. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1.
Li H; Peng SL; Cui Y; Fu QX; Zhou Y; Wang QL; Zhan LS; Zhong S
Protein Pept Lett; 2010 May; 17(5):547-54. PubMed ID: 19995342
[TBL] [Abstract][Full Text] [Related]
25. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals.
Ravet S; Scott-Algara D; Bonnet E; Tran HK; Tran T; Nguyen N; Truong LX; Theodorou I; Barré-Sinoussi F; Pancino G; Paul P
Blood; 2007 May; 109(10):4296-305. PubMed ID: 17272507
[TBL] [Abstract][Full Text] [Related]
26. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
[TBL] [Abstract][Full Text] [Related]
28. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
29. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
30. The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
Hens J; Jennes W; Kestens L
AIDS Res Ther; 2016; 13():15. PubMed ID: 26997965
[TBL] [Abstract][Full Text] [Related]
31. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.
O'Connor GM; Yamada E; Rampersaud A; Thomas R; Carrington M; McVicar DW
J Immunol; 2011 Sep; 187(5):2162-71. PubMed ID: 21804024
[TBL] [Abstract][Full Text] [Related]
32. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
Martin MP; Gao X; Lee JH; Nelson GW; Detels R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; Trowsdale J; Wilson M; O'Brien SJ; Carrington M
Nat Genet; 2002 Aug; 31(4):429-34. PubMed ID: 12134147
[TBL] [Abstract][Full Text] [Related]
33. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
34. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
[TBL] [Abstract][Full Text] [Related]
35. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
36. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of HLA-F expression by BK polyomavirus infection induces immune recognition by KIR3DS1-positive natural killer cells.
Koyro TF; Kraus E; Lunemann S; Hölzemer A; Wulf S; Jung J; Fittje P; Henseling F; Körner C; Huber TB; Grundhoff A; Wiech T; Panzer U; Fischer N; Altfeld M
Kidney Int; 2021 May; 99(5):1140-1148. PubMed ID: 33359499
[TBL] [Abstract][Full Text] [Related]
38. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
[TBL] [Abstract][Full Text] [Related]
39. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
